New insight into how cannabidiol takes effect in the brains of people with psychosis

News
1
4 Likes
2

Here’s the study paper:

Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis

2 Likes
3

Interesting review of the use of Epidiolex (99% cannabidiol) in people with refractory epilepsy syndromes:

4

There are a couple studies on clinicaltrials.gov right now.

One of them is on CBD and early schizophrenia. It is supposed to end March 2020. Although the publication of the results could take awhile.

Another one that is supposed to be ending this month studies how CBD affects microglia activation in SZ.

There are two others studying it as an antipsychotic ending in Dec 2020 and Dec 2021.